Infection Preventionists, Manufacturers Cope With Needleless Connectors Issue in Wake of FDA's Concerns

The infection prevention and control community is pondering the Food and Drug Administration (FDA)'s concerns regarding positive-displacement needleless connectors and the possible link to bloodstream infections (BSIs) and patient mortality.

Register to view the full article

Subscribing to premium content on Infection Control Today will give you access to reports, webinars and other high-value assets.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.